| Literature DB >> 35634010 |
Michael S Broder1, Sarah N Gibbs1, Irina Yermilov1.
Abstract
The RAND/UCLA modified Delphi panel method is a formal group consensus process that systematically and quantitatively combines expert opinion and evidence by asking panelists to rate, discuss, then re-rate items. The method has been used to develop medical society guidelines, other clinical practice guidelines, disease classification systems, research agendas, and quality improvement interventions. Traditionally, a group of experts meet in person to discuss results of a first-round survey. After the meeting, experts complete a second-round survey used to develop areas of consensus. During the COVID-19 pandemic, this aspect of the method was not possible. As such, we have adapted the method to conduct virtual RAND/UCLA modified Delphi panels. In this study, we present a targeted literature review to describe and summarize the existing evidence on the RAND/UCLA modified Delphi panel method and outline our adaptation for conducting these panels virtually. Transitioning from in-person to virtual meetings was not without challenges, but there have also been unexpected advantages. The method we describe here can be a cost-effective and efficient alternative for researchers and clinicians.Entities:
Keywords: COVID-19; Delphi panel; consensus; expert panel; pandemic; virtual meeting
Year: 2022 PMID: 35634010 PMCID: PMC9130741 DOI: 10.2147/JHL.S352500
Source DB: PubMed Journal: J Healthc Leadersh ISSN: 1179-3201
Figure 1RAND/UCLA modified Delphi panel process.
RAND/UCLA Modified Delphi Panel Examples
| Project Title | In Person /Virtual | Number of Panelists | Length of Meeting | Number of Items Rateda | Percent Disagreement from First-Round to Second-Round Ratingsb |
|---|---|---|---|---|---|
| Use of On-Demand Treatments for OFF Episodes in Parkinson's Disease: Guidance from a RAND/UCLA Modified Delphi Consensus Panel | Virtual | 12 (5 female, 7 male) | 7 hoursc | 432 | 67, 32 |
| Expert Consensus on the Testing and Medical Management of PIK3CA-Related Overgrowth Spectrum | Virtual | 13 (7 female, 6 male) | 7 hoursc | 217 (first-round), 115 (second-round) | 19, 17 |
| Expert Consensus on the Identification, Diagnosis, and Treatment of Neurotrophic Keratopathy | Virtual | 11 (4 female, 7 male) | 7 hoursc | 735 | 40, 6 |
| Estimates of Stage-Specific Preclinical Sojourn Time across 21 Cancer Types | Virtual | 10 (4 female, 6 male) | 6 hoursc | 624 | 13, 1 |
| Tapering Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia: Expert Consensus Based on the RAND/UCLA Modified Delphi Panel Method | Virtual | 10 (4 female, 6 male) | 6 hoursc | 432 | 20, 10 |
| Developing an Emergency Department Order Set for Sickle Cell Disease in Acute Pain | In person | 10 (9 female, 1 male) | 1–2 days (9 hours)d | 606 | 67, 43 |
| Development of a Severity Classification System for Sickle Cell Disease | In person | 10 (6 female, 4 male) | 1–2 days (9 hours)d | 640 | 64, 32 |
| Guidelines for Management of Urgent Symptoms in Patients with Cholangiocarcinoma and Biliary Stents or Catheters Using the Modified RAND/UCLA Delphi Process | In person | 15 (3 female, 12 male) | 1 day (6 hours)d | 480 (first-round), | 38, 10 |
| Follow-up Intervals in Patients with Cushing’s Disease: Recommendations from a Panel of Experienced Pituitary Clinicians | In person | 11 (6 female, 5 male) | 1 day (6 hours)d | 85 (first-round), 79 (second-round) | 34, 11 |
Notes: aA change in number of items represent expert-suggested alterations to the survey after the panel discussion. b Higher numbers are percent disagreement in first-round ratings; lower numbers are percent disagreement in second-round ratings; cTime spent logged into the virtual meeting. dPanelists typically travel to the meeting location the evening before the meeting and spend a full day (with breaks) in person at the meeting.